CR9171A - Nuevos compuestos - Google Patents
Nuevos compuestosInfo
- Publication number
- CR9171A CR9171A CR9171A CR9171A CR9171A CR 9171 A CR9171 A CR 9171A CR 9171 A CR9171 A CR 9171A CR 9171 A CR9171 A CR 9171A CR 9171 A CR9171 A CR 9171A
- Authority
- CR
- Costa Rica
- Prior art keywords
- new compounds
- alkyl
- ocf3
- het
- alkoxyalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0425766.3A GB0425766D0 (en) | 2004-11-23 | 2004-11-23 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9171A true CR9171A (es) | 2007-07-04 |
Family
ID=33548739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9171A CR9171A (es) | 2004-11-23 | 2007-06-07 | Nuevos compuestos |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1817281A1 (nl) |
JP (1) | JP4233596B2 (nl) |
KR (1) | KR100886294B1 (nl) |
CN (1) | CN101065355A (nl) |
AP (1) | AP2007004003A0 (nl) |
AR (1) | AR052243A1 (nl) |
AU (1) | AU2005308534A1 (nl) |
BR (1) | BRPI0518486A2 (nl) |
CA (1) | CA2589258A1 (nl) |
CR (1) | CR9171A (nl) |
EA (1) | EA011217B1 (nl) |
GB (1) | GB0425766D0 (nl) |
GT (1) | GT200500337A (nl) |
IL (1) | IL183191A0 (nl) |
MA (1) | MA29038B1 (nl) |
MX (1) | MX2007006138A (nl) |
NL (2) | NL1030485C2 (nl) |
NO (1) | NO20072486L (nl) |
PA (1) | PA8653501A1 (nl) |
PE (1) | PE20061056A1 (nl) |
SV (1) | SV2006002311A (nl) |
TN (1) | TNSN07201A1 (nl) |
TW (1) | TWI300776B (nl) |
UY (1) | UY29224A1 (nl) |
WO (1) | WO2006056884A1 (nl) |
ZA (1) | ZA200703910B (nl) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH628885A5 (en) * | 1978-01-01 | 1982-03-31 | Anphar Sa | Piperidine derivative |
GB0314054D0 (en) * | 2003-06-17 | 2003-07-23 | Pfizer Ltd | Amide derivatives as selective serotonin re-uptake inhibitors |
ES2305776T3 (es) * | 2003-06-17 | 2008-11-01 | Pfizer Inc. | Derivados de n-pirrolidin-3-il-amida como inhibidores de la re-captacion de serotonina y noradrenalina. |
-
2004
- 2004-11-23 GB GBGB0425766.3A patent/GB0425766D0/en not_active Ceased
-
2005
- 2005-11-18 EA EA200700920A patent/EA011217B1/ru not_active IP Right Cessation
- 2005-11-18 KR KR1020077014351A patent/KR100886294B1/ko not_active IP Right Cessation
- 2005-11-18 AU AU2005308534A patent/AU2005308534A1/en not_active Abandoned
- 2005-11-18 JP JP2007542360A patent/JP4233596B2/ja not_active Expired - Fee Related
- 2005-11-18 MX MX2007006138A patent/MX2007006138A/es active IP Right Grant
- 2005-11-18 CA CA002589258A patent/CA2589258A1/en not_active Abandoned
- 2005-11-18 AP AP2007004003A patent/AP2007004003A0/xx unknown
- 2005-11-18 CN CNA2005800401025A patent/CN101065355A/zh active Pending
- 2005-11-18 BR BRPI0518486-0A patent/BRPI0518486A2/pt not_active IP Right Cessation
- 2005-11-18 WO PCT/IB2005/003643 patent/WO2006056884A1/en active Application Filing
- 2005-11-18 EP EP05808510A patent/EP1817281A1/en not_active Withdrawn
- 2005-11-21 AR ARP050104866A patent/AR052243A1/es not_active Application Discontinuation
- 2005-11-21 PE PE2005001362A patent/PE20061056A1/es not_active Application Discontinuation
- 2005-11-22 GT GT200500337A patent/GT200500337A/es unknown
- 2005-11-22 NL NL1030485A patent/NL1030485C2/nl not_active IP Right Cessation
- 2005-11-22 TW TW094140922A patent/TWI300776B/zh active
- 2005-11-22 UY UY29224A patent/UY29224A1/es not_active Application Discontinuation
- 2005-11-23 PA PA20058653501A patent/PA8653501A1/es unknown
- 2005-11-23 SV SV2005002311A patent/SV2006002311A/es unknown
-
2006
- 2006-10-27 NL NL1032760A patent/NL1032760C2/nl not_active IP Right Cessation
-
2007
- 2007-05-14 IL IL183191A patent/IL183191A0/en unknown
- 2007-05-15 NO NO20072486A patent/NO20072486L/no not_active Application Discontinuation
- 2007-05-15 ZA ZA200703910A patent/ZA200703910B/xx unknown
- 2007-05-22 TN TNP2007000201A patent/TNSN07201A1/fr unknown
- 2007-05-23 MA MA29935A patent/MA29038B1/fr unknown
- 2007-06-07 CR CR9171A patent/CR9171A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20072486L (no) | 2007-06-20 |
EP1817281A1 (en) | 2007-08-15 |
AU2005308534A1 (en) | 2006-06-01 |
JP2008520646A (ja) | 2008-06-19 |
MX2007006138A (es) | 2007-07-19 |
PE20061056A1 (es) | 2006-11-08 |
EA200700920A1 (ru) | 2007-12-28 |
GT200500337A (es) | 2006-06-13 |
KR100886294B1 (ko) | 2009-03-04 |
CA2589258A1 (en) | 2006-06-01 |
KR20070086599A (ko) | 2007-08-27 |
TNSN07201A1 (fr) | 2008-11-21 |
NL1032760A1 (nl) | 2006-12-13 |
NL1030485A1 (nl) | 2006-05-24 |
NL1032760C2 (nl) | 2007-04-17 |
SV2006002311A (es) | 2006-09-14 |
JP4233596B2 (ja) | 2009-03-04 |
UY29224A1 (es) | 2006-06-30 |
ZA200703910B (en) | 2008-09-25 |
WO2006056884A1 (en) | 2006-06-01 |
PA8653501A1 (es) | 2006-06-02 |
AP2007004003A0 (en) | 2007-06-30 |
CN101065355A (zh) | 2007-10-31 |
EA011217B1 (ru) | 2009-02-27 |
NL1030485C2 (nl) | 2006-11-07 |
BRPI0518486A2 (pt) | 2008-11-18 |
IL183191A0 (en) | 2007-08-19 |
MA29038B1 (fr) | 2007-11-01 |
TWI300776B (en) | 2008-09-11 |
GB0425766D0 (en) | 2004-12-22 |
TW200626543A (en) | 2006-08-01 |
AR052243A1 (es) | 2007-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6290646A2 (es) | Derivados de oxadiazol activos sobre fosfato de esfingosina-1 | |
CO5690642A2 (es) | Compuestos de pirazolo[3,4-b]piridina, y su uso como inhibi- dores de fosfodiesterasa | |
DK1585739T3 (da) | Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer | |
MY144971A (en) | Prodrug of cinnamide compound | |
CO5611127A2 (es) | Derivados de indolilmaleimida | |
AR085150A1 (es) | Agentes moduladores de s1p | |
RS52546B (en) | 1H-BENZIMIDAZOL-4-CARBOXAMIDES SUBSTITUTED WITH QUATERNERN CARBON AT POSITION-2 ARE POWERFUL PARP INHIBITORS | |
PE20130155A1 (es) | Derivados de ariletinilo | |
AR055150A1 (es) | Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso | |
WO2010003809A3 (en) | Liquid oxyalkylene bridged bis- and tris-phosphite ester mixtures | |
NZ581438A (en) | Kallikrein 7 modulators | |
ECSP056232A (es) | Nuevos compuestos | |
AR043837A1 (es) | Pirazoles sustituidos | |
CO6341609A2 (es) | 5-heterociclilalquil-3-hidroxi-2-fenilciclopent-2-enonas como herbicidas. | |
MX2009012885A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco | |
HRP20070529T3 (en) | Imidazole derivatives as glutmate receptor antagonists | |
AR061806A1 (es) | Derivados de alquilpiridazina como inhibidores de 11b-hsd1 (t2d) | |
CO5640131A2 (es) | Compuestos de n-formil-hidroxilamina como inhibidores de pdf | |
MX2009012338A (es) | Compuestos organicos de azufre y su uso para controlar artropodos dañinos. | |
CO6321269A2 (es) | Derivados de benzoxazinona que actuan como agonistas de receptores adrenergicos beta 2 para el tratamiento de transtornos respiratorios | |
AR062679A1 (es) | Derivados de eter diarilico y usos de los mismos | |
CO6190608A2 (es) | Sal de potasio cristalina de analogos de lipoxina a4 | |
HK1155739A1 (en) | A benzimidazole derivative as a calcium channel blocker | |
ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
DE602007013730D1 (de) | Trehaloseverbindung und arzneimittel mit der verbindung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |